Improved prediction of knee osteoarthritis progression by genetic polymorphisms: the Arthrotest Study

Objective. The aim of this study was to develop a genetic prognostic tool to predict radiographic progression towards severe disease in primary knee OA (KOA) patients. Methods. This investigation was a cross-sectional, retrospective, multicentric association study in 595 Spanish KOA patients. Caucas...

ver descrição completa

Detalhes bibliográficos
Autores: Blanco, FJ, Moller, I, Romera, M, Rozadilla, A, Sanchez-Lazaro, JA, Rodriguez, A, Galvez, J, Fores, J, Monfort, J, Ojeda, S, Moragues, C, Caracuel, MA, Clavaguera, T, Valdes, C, Soler, JM, Orellana, C, Belmonte, MA, Martin, F, Gimenez, S, Ucar, E, Pous, J, Bartolome, N, Artieda, M, Szczypiorska, M, Tejedor, D, Martinez, A, Montell, E, Martinez, H, Herrero, M, Verges, J
Formato: artículo
Estado:Versión publicada
Fecha de publicación:2015
País:España
Recursos:Institut d’Investigació Biomèdica Sant Pau (IIB Sant Pau)
Repositorio:r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
OAI Identifier:oai:iibsantpau.fundanetsuite.com:p8613
Acesso em linha:https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=8613
Access Level:acceso abierto
Palavra-chave:knee osteoarthritis
single nucleotide polymorphism
radiographic progression
Descrição
Resumo:Objective. The aim of this study was to develop a genetic prognostic tool to predict radiographic progression towards severe disease in primary knee OA (KOA) patients. Methods. This investigation was a cross-sectional, retrospective, multicentric association study in 595 Spanish KOA patients. Caucasian patients aged >= 40 years at the time of diagnosis of primary KOA of Kellgren-Lawrence grade 2 or 3 were included. Patients who progressed to Kellgren-Lawrence score 4 or who were referred for total knee replacement within 8 years after diagnosis were classified as progressors to severe disease. Clinical variables of the initial stages of the disease (gender, BMI, age at diagnosis, OA in the contralateral knee, and OA in other joints) were registered as potential predictors. Single nucleotide polymorphisms and clinical variables with an association of P < 0.05 were included in the multivariate analysis using forward logistic regression. Results. A total of 23 single nucleotide polymorphisms and the time of primary KOA diagnosis were significantly associated with KOA severe progression in the exploratory cohort (n = 220; P < 0.05). The predictive accuracy of the clinical variables was limited: area under the curve (AUC) = 0.66. When genetic variables were added to the clinical model (full model), the prediction of KOA progression was significantly improved (AUC = 0.82). Combining only genetic variables (rs2073508, rs10845493, rs2206593, rs10519263, rs874692, rs7342880, rs780094 and rs12009), a predictive model with good accuracy was also obtained (AUC = 0.78). The predictive ability for KOA progression of the full model was confirmed on the replication cohort (two-sample Z-test; n = 62; P = 0.190). Conclusion. An accurate prognostic tool to predict primary KOA progression has been developed based on genetic and clinical information from OA patients.